No Data
No Data
There's Reason For Concern Over ICAD, Inc.'s (NASDAQ:ICAD) Massive 43% Price Jump
2 AI Stocks Under $5
ICAD, Inc. Announces Presentation of Four Novel AI-Driven Breast Cancer Research Abstracts at 2024 San Antonio Breast Cancer Symposium
SABCS 2024: New Research Assesses ICAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
Express News | ICAD Advances Fight Against Breast Cancer With FDA-Cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at Rsna 2024
ICAD Advances Fight Against Breast Cancer With FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at RSNA 2024